Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 10 studies | 39% ± 15% | |
GABAergic neuron | 8 studies | 49% ± 21% | |
glutamatergic neuron | 7 studies | 31% ± 14% | |
retinal ganglion cell | 6 studies | 65% ± 18% | |
cardiac muscle cell | 5 studies | 37% ± 8% | |
interneuron | 4 studies | 59% ± 25% | |
GABAergic amacrine cell | 3 studies | 22% ± 2% | |
OFF-bipolar cell | 3 studies | 55% ± 26% | |
retinal rod cell | 3 studies | 35% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 1539.02 | 2530 / 2642 | 70% | 2.75 | 497 / 705 |
ovary | 97% | 2031.19 | 175 / 180 | 9% | 0.25 | 37 / 430 |
heart | 96% | 1196.16 | 826 / 861 | 0% | 0 | 0 / 0 |
uterus | 62% | 162.74 | 106 / 170 | 7% | 0.26 | 30 / 459 |
skin | 51% | 105.35 | 919 / 1809 | 1% | 0.03 | 3 / 472 |
stomach | 23% | 51.52 | 84 / 359 | 2% | 0.06 | 7 / 286 |
lung | 11% | 19.37 | 65 / 578 | 7% | 0.21 | 80 / 1155 |
adipose | 11% | 19.52 | 135 / 1204 | 0% | 0 | 0 / 0 |
intestine | 10% | 26.25 | 96 / 966 | 0% | 0.01 | 2 / 527 |
kidney | 1% | 2.09 | 1 / 89 | 6% | 0.26 | 50 / 901 |
thymus | 2% | 2.99 | 11 / 653 | 4% | 0.32 | 22 / 605 |
eye | 0% | 0 | 0 / 0 | 5% | 0.08 | 4 / 80 |
spleen | 4% | 6.29 | 10 / 241 | 0% | 0 | 0 / 0 |
esophagus | 2% | 2.97 | 29 / 1445 | 2% | 0.02 | 3 / 183 |
breast | 2% | 3.18 | 9 / 459 | 1% | 0.03 | 12 / 1118 |
muscle | 2% | 4.16 | 19 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 2% | 5.95 | 30 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 4.69 | 1 / 258 | 2% | 0.18 | 4 / 230 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.03 | 3 / 178 |
prostate | 1% | 1.09 | 2 / 245 | 0% | 0.02 | 2 / 502 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.07 | 4 / 504 |
liver | 0% | 0 | 0 / 226 | 0% | 0.00 | 1 / 406 |
peripheral blood | 0% | 0.12 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_0010811 | Biological process | positive regulation of cell-substrate adhesion |
GO_0005604 | Cellular component | basement membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0005614 | Cellular component | interstitial matrix |
GO_0045202 | Cellular component | synapse |
GO_0032281 | Cellular component | AMPA glutamate receptor complex |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | VWC2 |
Protein name | Brorin (Brain-specific chordin-like protein) (von Willebrand factor C domain-containing protein 2) |
Synonyms | UNQ739/PRO1434 |
Description | FUNCTION: BMP antagonist which may play a role in neural development. Promotes cell adhesion (By similarity). . |
Accessions | Q2TAL6 ENST00000340652.5 |